NEUVASQ BIOTECHNOLOGIES (Public limited company)
NEUVASQ BIOTECHNOLOGIES is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0762.966.663. It was founded on 05-02-2021. Its registered office is in Charleroi. Its main activity is: Activities of head offices and management consultancy. Its annual accounts for 2025 report equity of € 6 308 765 and a loss of € 2 599 256. These accounts report 9.3 full-time equivalents. Addrly gives it a financial health grade of C, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for 2 of its last 4 financial years.
Information last updated on 17-10-2026.
Company information
Key figures of NEUVASQ BIOTECHNOLOGIES
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -2 599 256-3 % | € -2 519 895-26 % | € -2 002 399-80 % | € -1 111 908 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € 6 308 765+61 % | € 3 908 021+174 % | € 1 427 917-58 % | € 3 430 316 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 7 226 276+68 % | € 4 303 251+33 % | € 3 236 376-13 % | € 3 710 158 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € 641 586+15 % | € 556 541+17 % | € 475 433 | € -218 533 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | 9.3+13 % | 8.2+15 % | 7.1+145 % | 2.9 |
Financial estimate
- 5 Shareholders
- 8 Board links
Similar companies
Other companies in the same activity in Charleroi.
| Company | Town |
|---|---|
| COLOUR HOUSE INTERNATIONAL | 6041 Charleroi |
| Centre Albert | 6041 Charleroi |
| ARBIOS | 6041 Charleroi |
| ACTAPHONE | 6041 Charleroi |
| AFOREST BELGIUM | 6041 Charleroi |
| BIOPOLE ULB - CHARLEROI en abrégé BUC | 6041 Charleroi |
| SOJUREC | 6041 Charleroi |
| W.E.B. PROPERTY SERVICES | 6041 Charleroi |
Frequently asked questions
Is NEUVASQ BIOTECHNOLOGIES still active? Yes. The Crossroads Bank for Enterprises lists NEUVASQ BIOTECHNOLOGIES as active.
What is the VAT number of NEUVASQ BIOTECHNOLOGIES? The VAT number of NEUVASQ BIOTECHNOLOGIES is BE 0762.966.663.
When was NEUVASQ BIOTECHNOLOGIES founded? NEUVASQ BIOTECHNOLOGIES was founded on 05-02-2021.
What is the address of NEUVASQ BIOTECHNOLOGIES? The current registered office of NEUVASQ BIOTECHNOLOGIES is Rue Auguste Piccard 48, 6041 Charleroi.
When did NEUVASQ BIOTECHNOLOGIES last file annual accounts? The latest annual accounts of NEUVASQ BIOTECHNOLOGIES were filed on 23-06-2026.
Does NEUVASQ BIOTECHNOLOGIES file its annual accounts on time? NEUVASQ BIOTECHNOLOGIES filed its annual accounts within the legal deadline for 2 of its last 4 financial years. Late: 2022, 2024.
How many employees does NEUVASQ BIOTECHNOLOGIES have? NEUVASQ BIOTECHNOLOGIES employs 9.3 full-time equivalents according to its most recent annual accounts.
Is NEUVASQ BIOTECHNOLOGIES financially healthy? Addrly gives NEUVASQ BIOTECHNOLOGIES a financial health grade of C, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is NEUVASQ BIOTECHNOLOGIES profitable? The annual accounts of NEUVASQ BIOTECHNOLOGIES for 2025 show a loss of € 2 599 256.
What is the equity of NEUVASQ BIOTECHNOLOGIES? The equity of NEUVASQ BIOTECHNOLOGIES was € 6 308 765 at the close of the 2025 financial year.
Who are the directors of NEUVASQ BIOTECHNOLOGIES? The annual accounts of NEUVASQ BIOTECHNOLOGIES record 17 mandates. The names, roles and dates are visible with a free account.
Can NEUVASQ BIOTECHNOLOGIES receive Peppol e-invoices? Yes. NEUVASQ BIOTECHNOLOGIES is registered on the Peppol network and can receive structured electronic invoices.
What does NEUVASQ BIOTECHNOLOGIES do? The main activity of NEUVASQ BIOTECHNOLOGIES is: Activities of head offices and management consultancy.